Form F-10/A - Registration Statement for Securities of certain Canadian Issuers.: [Amend]
SEC Accession No. 0000912282-10-000605
Filing Date
2010-06-10
Accepted
2010-06-10 17:26:36
Documents
5

Document Format Files

Seq Description Document Type Size
1 oncolytics_f10a.htm F-10/A 335784
2 oncolytics_logo.jpg GRAPHIC 12620
3 reovirus.jpg GRAPHIC 16971
4 ERNST & YOUNG CONSENT ex5_1.htm EX-5.1 1515
5 ex5_1.jpg GRAPHIC 71184
  Complete submission text file 0000912282-10-000605.txt   477921
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-10/A | Act: 33 | File No.: 333-167250 | Film No.: 10891094
SIC: 2834 Pharmaceutical Preparations